Management of dyspnea in patients with chronic obstructive pulmonary disease

Wiener Medizinische Wochenschrift

Volumn 159, Issue 23-24, 2009, Pages 583-590

  Abernethy, Amy P ^a   Uronis, Hope E ^a   Wheeler, Jane L ^a   Currow, David C ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Analgesics; Chronic obstructive pulmonary disease (MeSH); Dyspnea (MeSH); Opioid (MeSH); Oxygen (MeSH); Palliative care (MeSH)

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; FUROSEMIDE; HELIOX; MIDAZOLAM; MORPHINE; OPIATE; OXYCODONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANOREXIA; BREATHING PATTERN; CASE MANAGEMENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONFUSION; CONSTIPATION; DYSPNEA; HUMAN; NONHUMAN; NUTRITIONAL SUPPORT; OXYGEN THERAPY; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; VOMITING;

COMBINED MODALITY THERAPY; DYSPNEA; HUMANS; PALLIATIVE CARE; PATIENT CARE TEAM; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

EID: 77949463456     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-009-0727-z     Document Type: Review

References (71)

1. WHO. World Health Report. Paper presented at: World Health Organization, 2000, Geneva
2. RJ Halbert S Isonaka 2006 International primary care respiratory group (IPCRG) guidelines: integrating diagnostic guidelines for managing chronic respiratory diseases in primary care Prim Care Respir J 15 13 19 10.1016/j.pcrj.2005.12.001 16701755 (Pubitemid 43155764)
3. CJ Murray AD Lopez 1996 Evidence-based health policy - lessons from the Global Burden of Disease Study Science 274 5288 740 743 10.1126/science.274. 5288.740 1:CAS:528:DyaK28XmsFKqtro%3D 8966556 (Pubitemid 26398244)
4. Murray CJL, Lopez AD (eds). The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press, 1996
5. RA Pauwels AS Buist PM Calverley CR Jenkins SS Hurd 2001 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med 163 1256 1276 1:STN:280: DC%2BD3MzisFGqtw%3D%3D 11316667
6. B Burrows RJ Knudson AE Camilli SK Lyle MD Lebowitz 1987 The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry Am Rev Respir Dis 135 788 793 1:STN:280:DyaL2s7ot1Kgtw%3D%3D 3565926
7. RA Pauwels CG Lofdahl LA Laitinen, et al. 1999 Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease N Engl J Med 340 1948 1953 10.1056/NEJM199906243402503 1:CAS:528:DyaK1MXkt1yitr0%3D 10379018 (Pubitemid 29288270)
8. JR Lunney J Lynn DJ Foley S Lipson JM Guralnik 2003 Patterns of functional decline at the end of life JAMA 289 2387 2392 10.1001/jama.289.18. 2387 12746362 (Pubitemid 37430171)
9. JR Lunney J Lynn C Hogan 2002 Profiles of older medicare decedents J Am Geriatr Soc 50 1108 1112 10.1046/j.1532-5415.2002.50268.x 12110073 (Pubitemid 34666319)
10. ATS. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med, 159: 321-340, 1999
11. R Mountain C Zwillich J Weil 1978 Hypoventilation in obstructive lung disease. The role of familial factors N Engl J Med 298 521 525 1:STN:280:DyaE1c7htlyqtA%3D%3D 625307
12. Y Kikuchi S Okabe G Tamura, et al. 1994 Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma N Engl J Med 330 1329 1334 10.1056/NEJM199405123301901 1:STN:280:DyaK2c3gtlagug%3D%3D 8152444 (Pubitemid 24136055)
13. MS Stulbarg WR Winn LE Kellett 1989 Bilateral carotid body resection for the relief of dyspnea in severe chronic obstructive pulmonary disease. Physiologic and clinical observations in three patients Chest 95 1123 1128 10.1378/chest.95.5.1123 1:STN:280:DyaL1M3htVSlsQ%3D%3D 2495905
14. AP Abernethy DC Currow P Frith BS Fazekas A McHugh C Bui 2003 Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ 327 7414 523 528 10.1136/bmj.327.7414.523 1:CAS:528:DC%2BD3sXotVehsrk%3D 12958109
15. JG Burdon MC Pain AR Rubinfeld A Nana 1994 Chronic lung diseases and the perception of breathlessness: a clinical perspective Eur Respir J 7 1342 1349 10.1183/09031936.94.07071342 1:STN:280:DyaK2M%2FhtVKntQ%3D%3D 7925915 (Pubitemid 24235055)
16. DC Currow AP Abernethy P Frith 2003 Morphine for management of refractory dyspnoea: Authors' reply BMJ 327 7426 1288 1289 10.1136/bmj.327.7426.1288-c
17. Leach RM. Palliative medicine and non-malignant, end-stage respiratory disease. In: Doyle D (ed) Oxford textbook of palliative medicine. 3rd ed. Oxford: Oxford Univ Press, 2005
18. JE Eckenhoff SR Oech 1960 The effects of narcotics and antagonists upon respiration and circulation in man. A review Clin Pharmacol Ther 1 483 524 1:CAS:528:DyaF3cXhtFamsr0%3D 13819208
19. JV Weil RE McCullough JS Kline IE Sodal 1975 Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal man N Engl J Med 292 1103 1106 1:CAS:528:DyaE2MXkslais78%3D 1128555
20. TV Santiago AC Pugliese NH Edelman 1977 Control of breathing during methadone addiction Am J Med 62 347 354 10.1016/0002-9343(77)90831-2 1:STN:280:DyaE2s7jtFynsA%3D%3D 842554
21. MH Kryger O Yacoub J Dosman PT Macklem NR Anthonisen 1976 Effect of meperidine on occlusion pressure responses to hypercapnia and hypoxia with and without external inspiratory resistance Am Rev Respir Dis 114 333 340 1:CAS:528:DyaE28XlslWrtb0%3D 973724
22. TV Santiago J Johnson DJ Riley NH Edelman 1979 Effects of morphine on ventilatory response to exercise J Appl Physiol 47 112 118 1:CAS:528: DyaE1MXltVagsrg%3D 468650
23. AL Jennings AN Davies JP Higgins JS Gibbs KE Broadley 2002 A systematic review of the use of opioids in the management of dyspnoea Thorax 57 939 944 10.1136/thorax.57.11.939 12403875 (Pubitemid 35316271)
24. E Bruera T MacEachern C Ripamonti J Hanson 1993 Subcutaneous morphine for dyspnea in cancer patients Ann Intern Med 119 906 907 1:STN:280: DyaK2c%2FivVeqtw%3D%3D 8215003
25. HF Kim ME Kunik VA Molinari, et al. 2000 Functional impairment in COPD patients: the impact of anxiety and depression Psychosomatics 41 465 471 10.1176/appi.psy.41.6.465 1:STN:280:DC%2BD3M7gvFygtA%3D%3D 11110109
26. P Mitchell-Heggs K Murphy K Minty, et al. 1980 Diazepam in the treatment of dyspnoea in the 'Pink Puffer' syndrome Q J Med 49 9 20 1:STN:280: DyaL3M%2FlsFCjtQ%3D%3D 6776586
27. AA Woodcock ER Gross DM Geddes 1981 Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers Br Med J (Clin Res Ed) 283 6287 343 346 10.1136/bmj.283.6287.343 1:STN:280:DyaL3M3jtlylsQ%3D%3D
28. D Sen G Jones PO Leggat 1983 The response of the breathless patient treated with diazepam Br J Clin Pract 37 232 233 1:STN:280:DyaL3s3otlaktg%3D%3D 6882655
29. GC Man K Hsu BJ Sproule 1986 Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease Chest 90 832 836 10.1378/chest.90.6.832 1:STN:280:DyaL2s%2FltlSisQ%3D%3D 3780329
30. JG Greene F Pucino JD Carlson M Storsved GL Strommen 1989 Effects of alprazolam on respiratory drive, anxiety, and dyspnea in chronic airflow obstruction: a case study Pharmacotherapy 9 34 38 1:STN:280:DyaL1M7mtVGhsQ%3D%3D 2922358
31. AH Navigante LC Cerchietti MA Castro MA Lutteral ME Cabalar 2006 Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer J Pain Symptom Manage 31 38 47 10.1016/j.jpainsymman.2005.06.009 1:CAS:528:DC%2BD28XisF2qtLs%3D 16442481 (Pubitemid 43143297)
32. SJ Garner FL Eldridge PG Wagner RT Dowell 1989 Buspirone, an anxiolytic drug that stimulates respiration Am Rev Respir Dis 139 946 950 1:CAS:528:DyaL1MXhvVGrsbY%3D 2930071
33. WB Mendelson JV Martin DM Rapoport 1990 Effects of buspirone on sleep and respiration Am Rev Respir Dis 141 1527 1530 1:CAS:528:DyaK3cXkslWit7Y%3D 2350096
34. P Argyropoulou D Patakas A Koukou P Vasiliadis D Georgopoulos 1993 Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease Respiration 60 216 220 10.1159/000196202 1:STN:280:DyaK2c%2FptVShug%3D%3D 8265878
35. NP Singh JA Despars DW Stansbury K Avalos RW Light 1993 Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety Chest 103 800 804 10.1378/chest.103.3.800 1:STN:280:DyaK3s7ptlGitg%3D%3D 8449072
36. LA Papp JR Weiss HE Greenberg, et al. 1995 Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders Am J Psychiatry 152 1531 1:STN:280:DyaK28%2FitFWlug%3D%3D 7573598
37. JW Smoller MH Pollack D Systrom RL Kradin 1998 Sertraline effects on dyspnea in patients with obstructive airways disease Psychosomatics 39 24 29 1:STN:280:DyaK1c7pvFCqug%3D%3D 9538672
38. BH Burns JB Howell 1969 Disproportionately severe breathlessness in chronic bronchitis Q J Med 38 277 294 1:STN:280:DyaE3c%2Fgs1Shtg%3D%3D 5343604
39. RA Mueller DB Lundberg GR Breese J Hedner T Hedner J Jonason 1982 The neuropharmacology of respiratory control Pharmacol Rev 34 255 285 1:CAS:528:DyaL3sXhtFyqsbc%3D 6185961
40. PG Ventresca GM Nichol PJ Barnes KF Chung 1990 Inhaled furosemide inhibits cough induced by low chloride content solutions but not by capsaicin Am Rev Respir Dis 142 143 146 1:CAS:528:DyaK3cXlt1Kgtrk%3D 2368961
41. S Bianco A Vaghi M Robuschi M Pasargiklian 1988 Prevention of exercise-induced bronchoconstriction by inhaled frusemide Lancet 2 8605 252 255 10.1016/S0140-6736(88)92540-8 1:STN:280:DyaL1c3nsFKnsg%3D%3D 2899239
42. S Bianco MG Pieroni RM Refini L Rottoli P Sestini 1989 Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions N Engl J Med 321 1069 1073 1:STN:280:DyaK3c%2FhsV2rtA%3D%3D 2797066
43. M Robuschi G Gambaro S Spagnotto A Vaghi S Bianco 1989 Inhaled frusemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction Pulm Pharmacol 1 187 191 10.1016/S0952-0600(89)80016-X 1:STN:280:DyaK383gtVSltA%3D%3D 2520344
44. KF Chung PJ Barnes 1992 Loop diuretics and asthma Pulm Pharmacol 5 1 7 10.1016/0952-0600(92)90011-5 1:CAS:528:DyaK2cXhvVait78%3D 1591461
45. T Nishino T Ide T Sudo J Sato 2000 Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea Am J Respir Crit Care Med 161 1963 1967 1:STN:280:DC%2BD3czhtFChtA%3D%3D 10852774
46. Ong KC, Kor AC, Chong WF, Earnest A, Wang YT. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 169: 1028-1033
47. SH Ahmedzai E Laude A Robertson G Troy V Vora 2004 A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion Br J Cancer 90 366 371 10.1038/sj.bjc.6601527 1:CAS:528:DC%2BD2cXksl2mug%3D%3D 14735178 (Pubitemid 38250630)
48. Cranston JM, Crockett A, Currow D. Oxygen therapy for dyspnoea in adults. Cochrane Database of Systematic Reviews, 2008(3): CD004769
49. GH Guyatt DA McKim P Austin, et al. 2000 Appropriateness of domiciliary oxygen delivery Chest 118 1303 1308 10.1378/chest.118.5.1303 1:STN:280:DC%2BD3M%2FkvFOguw%3D%3D 11083678
50. WJ O'Donohue Jr AL Plummer 1995 Magnitude of usage and cost of home oxygen therapy in the United States Chest 107 301 302 10.1378/chest.107.2.301 7842750
51. S Booth R Wade M Johnson S Kite M Swannick H Anderson 2004 The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine Respir Med 98 66 77 10.1016/j.rmed.2003.08.008 14959816 (Pubitemid 38100757)
52. JM Luce JA Luce 2001 Perspectives on care at the close of life. Management of dyspnea in patients with far-advanced lung disease: "once I lose it, it's kind of hard to catch it". [see comment] JAMA 285 1331 1337 10.1001/jama.285.10.1331 1:STN:280:DC%2BD3M7osFeqtA%3D%3D 11255389
53. AP Abernethy DC Currow P Frith B Fazekas 2005 Prescribing palliative oxygen: a clinician survey of expected benefit and patterns of use Palliat Med 19 168 170 15810762
54. E Stringer C McParland P Hernandez 2004 Physician practices for prescribing supplemental oxygen in the palliative care setting J Palliat Care 20 303 307 15690833
55. S Booth L Adams 2001 The shuttle walking test: a reproducible method for evaluating the impact of shortness of breath on functional capacity in patients with advanced cancer Thorax 56 146 150 10.1136/thorax.56.2.146 1:STN:280:DC%2BD3M7lsF2gtg%3D%3D 11209105 (Pubitemid 32142681)
56. S Booth S Silvester C Todd 2003 Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers Palliat Support Care 1 337 344 16594223
57. DA Seamark SD Blake CJ Seamark DM Halpin 2004 Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers. An interpretative phenomenological analysis Palliat Med 18 619 625 10.1191/0269216304pm928oa 1:STN:280:DC%2BD2crmvVeluw%3D%3D 15540670 (Pubitemid 39468109)
58. Dyspnea 1999 Mechanisms, assessment, and management: a consensus statement. American Thoracic Society Am J Respir Crit Care Med 159 321 340
59. S O'Neill DS McCarthy 1983 Postural relief of dyspnoea in severe chronic airflow limitation: relationship to respiratory muscle strength Thorax 38 595 600 10.1136/thx.38.8.595 6612651
60. JT Sharp WS Drutz T Moisan J Foster W Machnach 1980 Postural relief of dyspnea in severe chronic obstructive pulmonary disease Am Rev Respir Dis 122 201 211 1:STN:280:DyaL3M%2FhvFyntg%3D%3D 7416599
61. AL Barach 1974 Chronic obstructive lung disease: postural relief of dyspnea Arch Phys Med Rehabil 55 494 504 1:STN:280:DyaE2M%2Fnt1aiuw%3D%3D 4441261
62. AL Barach GJ Beck 1954 The ventilatory effects of the head-down position in pulmonary emphysema Am J Med 16 55 60 10.1016/0002-9343(54)90322-8 1:STN:280:DyaG2c%2FjsFWrsw%3D%3D 13114235
63. BL Tiep M Burns D Kao R Madison J Herrera 1986 Pursed lips breathing training using ear oximetry Chest 90 218 221 10.1378/chest.90.2.218 1:STN:280:DyaL283ntlGjtQ%3D%3D 3731893
64. Madge S, Edmond G. End-stage management of respiratory disease. In: Esmond G (ed) Respiratory Nursing. London: Bailliere Tindall, pp 229-240, 2001
65. DO Wilson RM Rogers MH Sanders BE Pennock JJ Reilly 1986 Nutritional intervention in malnourished patients with emphysema Am Rev Respir Dis 134 672 677 1:STN:280:DyaL2s%2FisVSqsQ%3D%3D 3767123
66. H Sahebjami JT Doers ML Render TL Bond 1993 Anthropometric and pulmonary function test profiles of outpatients with stable chronic obstructive pulmonary disease Am J Med 94 469 474 10.1016/0002-9343(93)90080-9 1:STN:280: DyaK3s3mvFyktw%3D%3D 8498391 (Pubitemid 23142960)
67. DO Wilson RM Rogers EC Wright NR Anthonisen 1989 Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial Am Rev Respir Dis 139 1435 1438 1:STN:280:DyaL1M3ntFaqsA%3D%3D 2658702
68. Ferreira IM, Brooks D, Lacasse Y, Goldstein RS, White J. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2005(2): CD000998
69. J Efthimiou J Fleming C Gomes SG Spiro 1988 The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease Am Rev Respir Dis 137 1075 1082 1:STN:280:DyaL1M%2FmtVKmsQ%3D%3D 3057956
70. KE Otte P Ahlburg F D'Amore M Stellfeld 1989 Nutritional repletion in malnourished patients with emphysema J Parenter Enteral Nutr 13 152 156 10.1177/0148607189013002152 1:STN:280:DyaL1M3hslamtQ%3D%3D
71. MC Steiner RL Barton SJ Singh MD Morgan 2003 Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial Thorax 58 745 751 10.1136/thorax.58.9.745 1:STN:280: DC%2BD3svgvVCksg%3D%3D 12947128 (Pubitemid 37094048)